7.02
                                            前日終値:
              $6.61
            開ける:
              $6.58
            24時間の取引高:
                3.26M
            Relative Volume:
              1.47
            時価総額:
                $2.60B
            収益:
              $9.47B
            当期純損益:
              $-178.00M
            株価収益率:
              -14.62
            EPS:
                -0.48
            ネットキャッシュフロー:
                $1.01B
            1週間 パフォーマンス:
              +13.23%
            1か月 パフォーマンス:
              +8.84%
            6か月 パフォーマンス:
                +32.45%
            1年 パフォーマンス:
              -23.70%
            Bausch Health Companies Inc Stock (BHC) Company Profile
名前
                  
                      Bausch Health Companies Inc
                    
                セクター
                  電話
                  
                      514-744-6792
                    
                住所
                  
                      2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
                    
                BHC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS | 
|---|---|---|---|---|---|---|
|   
                          
                                BHC
                            
                             Bausch Health Companies Inc | 7.02 | 2.45B | 9.47B | -178.00M | 1.01B | -0.48 | 
|   
                          
                                ZTS
                            
                             Zoetis Inc | 144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 | 
|   
                          
                                TAK
                            
                             Takeda Pharmaceutical Co Adr | 13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 | 
|   
                          
                                HLN
                            
                             Haleon Plc Adr | 9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 | 
|   
                          
                                TEVA
                            
                             Teva Pharmaceutical Industries Ltd Adr | 20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 | 
|   
                          
                                UTHR
                            
                             United Therapeutics Corp | 445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 | 
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 | 
|---|---|---|---|
| 2024-08-02 | ダウングレード | Piper Sandler | Neutral → Underweight | 
| 2024-07-10 | 開始されました | Raymond James | Mkt Perform | 
| 2023-09-20 | アップグレード | Jefferies | Hold → Buy | 
| 2023-06-16 | ダウングレード | TD Cowen | Outperform → Market Perform | 
| 2022-07-29 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform | 
| 2022-07-29 | ダウングレード | Truist | Buy → Hold | 
| 2022-07-28 | ダウングレード | JP Morgan | Overweight → Neutral | 
| 2022-06-13 | 再開されました | JP Morgan | Overweight | 
| 2021-03-24 | ダウングレード | BofA Securities | Neutral → Underperform | 
| 2021-02-17 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform | 
| 2021-01-22 | ダウングレード | Piper Sandler | Overweight → Neutral | 
| 2020-09-17 | アップグレード | BofA Securities | Underperform → Neutral | 
| 2020-08-24 | 繰り返されました | H.C. Wainwright | Buy | 
| 2020-06-17 | 繰り返されました | H.C. Wainwright | Buy | 
| 2020-04-24 | 開始されました | Citigroup | Buy | 
| 2020-04-02 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight | 
| 2020-01-29 | ダウングレード | Wolfe Research | Outperform → Peer Perform | 
| 2020-01-22 | アップグレード | Wells Fargo | Underweight → Equal Weight | 
| 2019-12-12 | アップグレード | JP Morgan | Neutral → Overweight | 
| 2019-12-02 | 開始されました | Goldman | Neutral | 
| 2019-10-25 | 開始されました | Cowen | Outperform | 
| 2019-09-12 | 開始されました | Guggenheim | Buy | 
| 2019-08-15 | アップグレード | TD Securities | Hold → Buy | 
| 2019-07-19 | 開始されました | Wolfe Research | Outperform | 
| 2019-06-11 | 再開されました | Barclays | Overweight | 
| 2019-05-13 | アップグレード | JP Morgan | Underweight → Neutral | 
| 2019-03-20 | 開始されました | SunTrust | Buy | 
| 2019-01-02 | アップグレード | Piper Jaffray | Neutral → Overweight | 
| 2018-11-05 | アップグレード | Morgan Stanley | Equal-Weight → Overweight | 
| 2018-09-13 | アップグレード | Piper Jaffray | Underweight → Neutral | 
                    すべてを表示
                     
                  
                Bausch Health Companies Inc (BHC) 最新ニュース
Bausch Health Cos (NYSE:BHC) Shares Gap UpHere's What Happened - MarketBeat
Bausch Health Companies (TSE:BHC) Stock Price Up 15.9%Here's Why - MarketBeat
5 Undervalued Stocks Under $10 Poised for Double-Digit Rebounds - Investing.com
Europe Photodynamic Therapy Market Size, Trends, Leading Applications and Pricing Benchmarks (2025-2033) Featuring Gladerma, Sun Pharmaceutical, Biofrontera, Lumibird, Bausch Health Companies and More - GlobeNewswire
Analysts Conflicted on These Healthcare Names: Bausch Health Companies (BHC), Thermo Fisher (TMO) and Mineralys Therapeutics, Inc. (MLYS) - The Globe and Mail
Bausch Health Companies Inc. (NYSE:BHC) Q3 2025 Earnings Call Transcript - MSN
Why Bausch Health Is A Buy After Rising 10% On Third Quarter Results - Seeking Alpha
Is Bausch Health Companies Inc. stock supported by strong fundamentalsLong Setup & Free Technical Confirmation Trade Alerts - newser.com
What RSI levels show for Bausch Health Companies Inc. stockJuly 2025 Momentum & Low Drawdown Momentum Ideas - newser.com
Should you wait for a breakout in Bausch Health Companies Inc.Entry Point & Safe Entry Momentum Stock Tips - newser.com
Is Bausch Health Companies Inc. stock a smart buy before Fed meetingDollar Strength & Growth Focused Investment Plans - newser.com
Is Bausch Health Companies Inc. stock positioned for digital transformationJuly 2025 Institutional & Fast Momentum Stock Entry Tips - newser.com
Can Bausch Health Companies Inc. stock rebound after recent weaknessJuly 2025 Catalysts & Community Consensus Stock Picks - newser.com
How Bausch Health Companies Inc. stock reacts to fiscal policiesSell Signal & Community Consensus Trade Alerts - newser.com
Institutional scanner results for Bausch Health Companies Inc.July 2025 Opening Moves & Reliable Trade Execution Plans - newser.com
Published on: 2025-10-31 00:48:51 - newser.com
How to interpret RSI for Bausch Health Companies Inc. stock2025 Macro Impact & Weekly Chart Analysis and Guides - newser.com
Bausch Health Companies Inc (BHC) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Bausch Health (BHC) Q3 2025 Earnings Transcript - AOL.com
Bausch Health Companies Inc. (BHC) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Bausch: Q3 Earnings Snapshot - CTPost
BHC Stock Up on Q3 Earnings Beat, Salix and Solta Drive Sales - TradingView
Bausch Health Companies Inc. SEC 10-Q Report - TradingView
Will Bausch Health Companies Inc. stock sustain high P E ratiosJuly 2025 Summary & Free Safe Entry Trade Signal Reports - newser.com
Is Bausch Health Companies Inc. stock bottoming out2025 Investor Takeaways & Weekly Momentum Picks - newser.com
How supply chain issues affect Bausch Health Companies Inc. stockPortfolio Risk Report & AI Driven Stock Movement Reports - newser.com
Why analysts remain bullish on Bausch Health Companies Inc. stockIPO Watch & Weekly Watchlist for Hot Stocks - newser.com
Published on: 2025-10-30 00:49:28 - newser.com
Bausch Health raises 2025 revenue guidance to $5B-$5.1B while strengthening Solta and Salix growth - MSN
Is Bausch Health Companies Inc. (BVF) stock worth buying before Fed action2025 Technical Overview & Safe Capital Growth Stock Tips - newser.com
Bausch Health Q3 Adjusted Earnings and Revenue, Advance - 富途牛牛
Bausch Health Companies Turns To Profit In Q3; Stock Up In After-hours - Nasdaq
Bausch Health Companies Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Bausch Health Turns A Profit And Lifts Its Outlook - Finimize
Bausch Health Raises Forecast After Beating Expectations Again - Finimize
Bausch Health rises on 2025 revenue, EBITDA guidance boost, Q3 beats - Seeking Alpha
Bausch & Lomb Corp SEC 10-Q Report - TradingView
Bausch Health Brief: Q3 GAAP Net Income Attributable of US$179 Million and GAAP Net Income of $181 Million - MarketScreener
Bausch Health Announces Third Quarter 2025 Results - ACCESS Newswire
Bausch Health leaves Medicaid, 340B program, STAT reports - TipRanks
Zacks Research Issues Pessimistic Outlook for BHC Earnings - MarketBeat
What is Zacks Research's Forecast for TSE:BHC Q3 Earnings? - MarketBeat
Is Bausch Health Companies Inc. stock inflation resilient2025 Growth vs Value & Fast Exit and Entry Strategy Plans - newser.com
Eye Health Supplements Market Is Booming Worldwide 2025-2032 | - openPR.com
Bausch Health Companies Inc (BHC) 財務データ
収益
当期純利益
現金流量
EPS
                大文字化:
                 
                  | 
                ボリューム (24 時間):
                 
            
         
                     
                             ストックスクリーナーアプリを入手
                    ストックスクリーナーアプリを入手